Becton, Dickinson Aktie

226,86USD 0,41USD 0,18%
Becton, Dickinson für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN: 857675 / ISIN: US0758871091
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 99,83
The Vanguard Group, Inc. 9,04
Vanguard Group, Inc. (Subfiler) 8,74
State Street Corp. 4,83
T Rowe Price Associates, Inc. (13F Subfiler) 4,53
T. Rowe Price Associates, Inc. (IM) 3,59
Vanguard Total Stock Market ETF 3,16
T. Rowe Price Investment Management, Inc. 3,08
BlackRock Fund Advisors 2,87
Vanguard 500 Index Fund 2,65
BlackRock Institutional Trust Co. NA 2,18
Geode Capital Management LLC 2,17
Morgan Stanley Investment Management Ltd. 2,08
Generation Investment Management LLP 2,06
T Rowe Price Capital Appreciation Fund 2,04

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 72 000 75 000 77 000 73 000 74 000
Umsatz pro Mitarbeiter in Mio. EUR 0,24 0,27 0,25 0,27 0,27

Bilanz (in Mio. USD) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 8 969 8 838 8 141 8 676 10 468
Summe Anlagevermögen 45 043 45 028 44 793 44 104 46 818
Summe Aktiva 54 012 53 866 52 934 52 780 57 286

Bilanz (in Mio. USD) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 30 247 30 189 27 652 26 983 31 396
Summe Eigenkapital 23 765 23 677 25 282 25 797 25 890
Summe Passiva 54 012 53 866 52 934 52 780 57 286

Adresse

1 Becton Drive, 07417-1880 Franklin Lakes
Telefon +1 (201) 847-6800
Internet http://www.bd.com

Management

Ami E. Simunovich
Chief Quality & Regulatory Officer, Executive VP
Antoine Ezell
Chief Marketing Officer & EVP-North America
Antoinette F. Segreto
Senior Vice President-Taxes
Bertram L. Scott
Lead Independent Director
Brooke Story
President-Integrated Diagnostic Solutions
Carrie L. Byington
Independent Director
Catherine M. Burzik
Independent Director
Christopher Ian Montague Jones
Independent Director
Christopher J. DelOrefice
Chief Financial & Accounting Officer, EVP
Claire M. Fraser-Liggett
Independent Director
Claudia Curtis
Chief Ethics & Compliance Officer, Senior VP
David Shan
Chief Quality Officer & Executive Vice President
Denise Russell Fleming
Chief Information Officer & EVP-Technology
Ebonee Lewis
Chief Employment Counsel
Elizabeth McCombs
Chief Technology Officer & Executive VP
Gary Michael DeFazio
Secretary, Senior VP & Associate General Counsel
Gregory Rodetis
Treasurer, Senior VP & Head-Investor Relations
Jeffrey William Henderson
Independent Director
Joanne Waldstreicher
Independent Director
Joseph M. Smith
Chief Scientific Officer & Senior Vice President
Michael Feld
Executive Vice President & President-Life Sciences
Michelle Quinn
Executive Vice President & General Counsel
Rishi Grover
Chief Integrated Supply Chain Officer & EVP
Robert Andrew Eckert
Independent Director
Ronald P. Silverman
Chief Medical Officer & Executive Vice President
Shana Carol Neal
Chief People Officer & Executive Vice President
Stephen O. Richard
Chief Risk Officer & Senior Vice President
Thomas E. Polen
Chairman, President & Chief Executive Officer
Thomas J. Spoerel
Senior Vice President & Controller
Timothy M. Ring
Independent Director
Vishy Kanda
Chief Strategy Officer & Senior Vice President
William M. Brown
Independent Director